ArticleCurrent medicinal chemistry2026
Enhancing InceptionResNet to Diagnose COVID-19 from Medical Images.
Article in Current medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
introductionThis investigation delves into the diagnosis of COVID-19, using X-ray images generated by way of an effective deep learning model. In terms of assessing the COVID-19 diagnosis learning model, the methods currently employed tend to focus on the accuracy rate level, while neglecting several significant assessment parameters. These parameters, which include precision, sensitivity and specificity, significantly, F1-score, and ROC-AUC influence the performance level of the model. In this paper, we have improved the InceptionResNet and called Enhanced InceptionResNet with restructured parameters termed, "Enhanced InceptionResNet," which incorporates depth-wise separable convolutions to enhance the efficiency of feature extraction and minimize the consumption of computational resources.
methodsFor this investigation, three residual network (ResNet) models, namely Res- Net, InceptionResNet model, and the Enhanced InceptionResNet with restructured parameters, were employed for a medical image classification assignment. The performance of each model was evaluated on a balanced dataset of 2600 X-ray images. The models were subsequently assessed for accuracy and loss, as well subjected to a confusion matrix analysis.
resultsThe Enhanced InceptionResNet consistently outperformed ResNet and InceptionResNet in terms of validation and testing accuracy, recall, precision, F1-score, and ROC-AUC demonstrating its superior capacity for identifying pertinent information in the data. In the context of validation and testing accuracy, our Enhanced InceptionRes- Net repeatedly proved to be more reliable than ResNet, an indication of the former's capacity for the efficient identification of pertinent information in the data (99.0% and 98.35%, respectively), suggesting enhanced feature extraction capabilities.
conclusionThe Enhanced InceptionResNet excelled in COVID-19 diagnosis from chest X-rays, surpassing ResNet and Default InceptionResNet in accuracy, precision, and sensitivity. Despite computational demands, it shows promise for medical image classification. Future work should leverage larger datasets, cloud platforms, and hyperparameter optimisation to improve performance, especially for distinguishing normal and pneumonia cases.
Indexed as
Identifiers
40734430What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.